Skip to main content


Thank you to those who attended the Virtual Experience!

If you weren't able to attend, check out the coverage in the Meeting Newsroom or sign up for On-Demand Access!


Virtual Experience
Where practical approaches shape the future of lung cancer care.
Save the Date for 2021

September 30 -  October 2, 2021
November 11  -  November 13, 2021

Formerly known as Perspectives in Thoracic Oncology, the lung cancer meeting you know and love has undergone a makeover. With an updated name to reflect a more pronounced focus on targeted therapies, biomarker testing and precision medicine, this conference will be more practical than ever. Personalized Therapies in Thoracic Oncology goes beyond chemotherapy and focuses on the best way to treat your patients when traditional methods aren't cutting it. 

Your Go-To Meeting on Thoracic Malignancies

When it comes to your career, staying aware of the latest research, advances, and treatment options is imperative to the outcome of your patients’ illness. That’s why, at Personalized Therapies in Thoracic Oncology, we bring you the best speakers in the field to address the most critical topics facing those with lung cancer. 

Years of Innovation
Expert Faculty
AMA/CME Credits
Who Should Attend?

This activity is designed to meet the educational needs of all healthcare professionals interested in the care and treatment of patients with thoracic malignancies.

Medical Oncologists
Radiation Oncologists
Thoracic Surgeons
Diagnostic Radiologists
Clinical Researchers & Research Personnel
Nurse Practitioners
Physician Assistants
Meet the Chairs
Meeting Chair
Corey Langer, MD
Abramson Cancer Center
University of Pennsylvania
Philadelphia, PA
Edward Garon, MD
UCLA Medical Center
Santa Monica, CA
What sets Perspectives in Thoracic Oncology apart from other conferences in the lung cancer space are the true thoracic experts that share relevant updates and perspectives in an intimate setting. I am looking forward to discussing the emerging strategies for adjuvant therapies in early stage NSCLC."

Christine Ciunci, MD, MSCE
Abramson Cancer Center
University of Pennsylvania 

I have been attending Perspectives in Thoracic Oncology for the last 7 to 8 years and find the breadth of material presented and the depth of discussion of the material rewarding. It has reinforced my current knowledge of the science of lung cancer and its rapidly evolving treatment that includes biologic agents, conventional chemotherapy, radiation therapy, and new approaches. The back and forth discussions of treatment options has been stimulating. I will be attending this year's meeting and into the future."

Gary Smith, MD
Pulmonary Associates of Lubbock
Lubbock, TX

I chose to be a part of Perspectives in Thoracic Oncology because of the cutting edge topics being discussed. I enjoy the smaller, close-knit community feel of this meeting."

Charu Aggarwal, MD
Abramson Cancer Center
University of Pennsylvania 

As a nurse practitioner specializing in lung cancer, I look forward to The Perspectives in Thoracic Oncology Conference each year. I am never disappointed as the topics span from screening and smoking cessation to various treatment modalities, as well as updates on trials. I credit this annual conference to the practice improvements that our multidisciplinary team makes annually."

April Plank, DNP
The Center for Lung Cancer Screening and Prevention
Stony Brook, NY


Keep Me Informed